Dextromethorphan HBr. and Guaifenesin
NDC 57237-312, Dextromethorphan HBr. and Guaifenesin, solution, from Rising Pharma Holdings, Inc..
- Product NDC
- 57237-312
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012.85
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57237-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROMETHORPHAN HYDROBROMIDE10 mg/5mL
- GUAIFENESIN100 mg/5mL
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57237-312-51 | 57237031251 | 100 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (57237-312-51) / 5 mL in 1 CUP, UNIT-DOSE (57237-312-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 57237-312 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57237-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57237-312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.